Bioimaging: Employing Tryptone as a General Phase Transfer Agent to Produce Renal Clearable Nanodots for Bioimaging (Small 30/2015). Issue 30 (August 2015)

• Record Type: Journal Article
• Authors: Liu, Fuyao; He, Xiuxia; Zhang, Junping; Zhang, Huimao; Wang, Zhenxin
• Is Part Of: Small. Volume 11:Issue 30(2015)
• Page Start: 3618
• Page End: 3618
• Publication Date: 2015-08
• Subjects: Nanotechnology -- Periodicals; Nanoparticles -- Periodicals; Microtechnology -- Periodicals; 620.5
• DOI: 10.1002/smll.201570178
• Languages: English
• ISSNs: 1613-6810

Abstract

<abstract abstract-type="graphical" xml:lang="en" id="smll201570178-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <p>A simple, versatile, and inexpensive strategy is developed by H. Zhang, Z. Wang, and co‐workers for transferring small hydrophobic nanoparticles into an aqueous phase using raw tryptone as a phase‐transfer agent. On page 3676, using tryptone‐NaGdF₄ nanodots as typical examples, the nanodots are found to have excellent colloidal stability, outstanding MRI‐enhancing performance, efficient renal clearance, are nontoxic, and have an EPR‐based tumor targeting ability. Furthermore, the as‐transferred hydrophilic nanodots can be readily adapted by additional functionalization for various bioapplications. <graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgj2cr1rv5b" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></p> </abstract>